Immunoassay
Singulex Raises $19.1 Million to Advance Clinical Immunoassays for Drug Development and Health Care
Published in Drug Week, June 22nd, 2007
Singulex, Inc. announced it has raised $19.1 million in a private financing led by OrbiMed Advisors, LLC and joined by existing investors, Fisk Ventures, Prolog Ventures and Advantage Capital. The financing will be used to advance the scope and development of the company's commercial diagnostic solutions. Singulex's customizable assays and single molecule detection platform can monitor protein biomarkers from normal to disease levels, giving the necessary information for drug development and health care decisions. In conjunction with the financing, Singulex announced the addition of Carl Gordon, Ph.D., partner of OrbiMed, to the company's Board of Directors.
"We are in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-06-22)
More Articles from Drug Week
- Aging
Dietary Preferences and Patterns May Be Linked to Genes - Angiogenesis
Molecular Markers Predict Tumor Recurrence - Angiology
FDA Approves Ostial Pro Stent Positioning System - Angioplasty
Coronary Stents: Overview of This Common Tool to Keep Clogged Arteries Open - Arthritis
University of Manchester researchers reveal clues to new genes behind rheumatoid arthritis - Breast Cancer
Brain-boosting pill alleviates post-chemotherapy fogginess - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
